Inosine

DB04335

small molecule experimental investigational

Deskripsi

A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)

Struktur Molekul 2D

Berat 268.2261
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Ingested inosine is absorbed from the small intestine.

Metabolisme

In the liver, inosine may be catabolized by a series of reactions culminating in the production of uric acid and also may be metabolized to adenine- and guanine-containing nucleotides. Inosine not metabolized in the liver is transported via the systemic circulation and distributed to various tissues of the body, where it is metabolized in similar fashion as in the liver. Uric acid, the purine end-product of inosine catabolism, is excreted in the urine.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

0 Data
Tidak ada data.

Target Protein

Purine nucleoside phosphorylase PNP
IAG-nucleoside hydrolase
Purine nucleoside phosphorylase DeoD-type deoD

Referensi & Sumber

Synthesis reference: U.S. Patent 3,049,536 U.S. Patent 3,111,459

Contoh Produk & Brand

Produk: 1 • International brands: 3
Produk
  • Rejuvesol
    Solution • - • Extracorporeal • US • Approved
International Brands
  • Catacol — Alcon
  • Inotin
  • Lumiclar — Valeant

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul